@article{JTD13857,
author = {Allen Murga and Hannah Copeland and Rachel Hargrove and Jason M. Wallen and Salman Zaheer},
title = {Treatment for sternoclavicular joint infections: a multi-institutional study},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {6},
year = {2017},
keywords = {},
abstract = {Background: Sternoclavicular joint (SCJ) infections are rare and difficult to manage. Surgery is necessary for treatment.
Methods: A retrospective chart review of the university hospital and Veterans Administration (VA) hospitals of all patients treated for SCJ infections since 2001 was conducted. Fifteen [15] patients were identified and evaluated for the types of infections, risk factors, treatments and survival.
Results: All 15 patients were symptomatic including: pain [13], erythema [9], purulent drainage [3], fever greater than 38.3 ℃ [2], and leukocytosis [9]. The associated medical problems included: diabetes mellitus (DM), hypertension (HTN) and renal failure. All patients underwent intraoperative joint resection. Sixtyseven percent (67%) of intraoperative wound cultures grew staphylococcus aureus. Fourteen patients were discharged on intravenous antibiotics. The follow-up ranged between 1 week–11 months. Thirteen patients are currently alive without infection. Two patients died: 1 of sepsis and 1 of unknown causes after discharge.
Conclusions: Symptomatic SCJ infections require surgical intervention. The most common organism was staphylococcus aureus.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/13857}
}